Search NLS News

We are again partnering with a EQL Pharma – an entrepreneurial pharmaceutical company focusing on simplicity and efficiency to be able to deliver cost-efficient medicines of highest quality to pharmacies and hospitals, primarily in the Nordic region. The company is growing in a rapid speed, and we are looking for their next star, i.e., a […]

Isa Lindgren has been intrigued by all things science since she was a child. As Manager of Analytical Development at NorthX Biologics she gets to integrate her fascination with a new-found interest in business development and intrapreneurship. NorthX offers services and support in the development and manufacturing of biologics used in vaccines, gene therapy and […]

Novo Nordisk has announced plans to invest in the expansion of existing facilities in Bagsværd, Denmark. The plans also include the construction of a new plant located in extension of the existing facilities, states the company in its press release. Supply the company’s global clinical trials The investment will establish additional capacity in R&D for […]

Copenhagen Science City has one of Europe’s highest concentrations of education and research in the fields of medicine, health and natural sciences. The development of Copenhagen Science City started during the financial crisis, 2007-2008, when the Danish government wanted to help reduce unemployment and get some power back into the economy, describes Kristoffer Klebak, Head […]

The new project, PD-BT2238, combines a selective alpha-synuclein oligomer targeting antibody with BioArctic’s Brain Transporter technology, to increase exposure of the antibody in the brain, with the aim of increasing efficacy of a potential treatment in Parkinson’s disease. BioArctic’s aim is to develop an antibody treatment targeting soluble aggregated forms of alpha-synuclein, a protein that […]

The Board of LINK Medical has announced the appointment of Sissel Lønning Andresen as the company’s new CEO. Ola Gudmundsen will remain in the company in a strategic role where he will work closely with Lønning Andresen, and support the Business Development and Commercial Operations team. He will remain an important owner of the company […]

Olink Holding has announced the 2022 winner of the young researchers’ award, Novelties in Biomarkers, Maria Martin-Grau at the University of Valencia, Spain. Novelties in Biomarkers is an annual award established in 2019 by Olink Proteomics with the purpose of encouraging and motivating young scientists in the use of biomarker discovery in their research. “To […]

The company has named Johan Johansson as Vice President of Operations, Research and Development. He begins the role immediately at the company’s headquarters in Lund. “Johan brings not only proven success in Operations, Research and Development, but also specific experience with devices for temperature management as well as side effects of chemotherapy. This expertise aligns […]

Evaxion Biotech has announced clinical data from the first-in-human study of its DNA-based cancer immunotherapy, EVX-02. In the clinical study, EVX-02 is given in combination with a checkpoint inhibitor and targets cancer mutations, neoantigens, in patients with resected melanoma. The company reported encouraging interim safety and immunogenicity data from the Phase 1/2a study of its […]

Abera Bioscience has found the right recipe for giving its innovative and versatile vaccine platform the best possible conditions to succeed. Uppsala-based Abera Bioscience was founded ten years ago, as a spin-out from the biosimilars company Xbrane Bioscience. Maria Alriksson, CEO of Abera and former CEO of Xbrane, describes the process of separating the two […]